Age-independent rise of inflammatory scores may contribute to accelerated aging in multi-morbidity

Oncotarget

Volumn 6, Issue 3, 2015, Pages 1414-1421

  Stepanova, Maria ^a,b   Rodriguez, Edgar ^a   Birerdinc, Aybike ^a,b   Baranova, Ancha ^a,b,c,d  

^a GEORGE MASON UNIVERSITY   (United States)

^b Inova Health Systems   (United States)

^c RESEARCH CENTRE FOR MEDICAL GENETICS   (Russian Federation)

^d Atlas Biomed Group   (Russian Federation)

Author keywords

Aging; C reactive protein; Glasgow prognostic score; Multi morbidity; Systemic inflammation

Indexed keywords

C REACTIVE PROTEIN; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGING; ARTICLE; BODY MASS; CHRONIC DISEASE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; GLASGOW PROGNOSTIC SCORE; HEALTH SURVEY; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MORBIDITY; NEUTROPHIL; SCORING SYSTEM; GLASGOW OUTCOME SCALE; METABOLISM; MIDDLE AGED; PATHOLOGY; RISK FACTOR; UNITED STATES;

ADULT; AGE FACTORS; AGING; C-REACTIVE PROTEIN; CHRONIC DISEASE; FEMALE; GLASGOW OUTCOME SCALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MORBIDITY; RISK FACTORS; UNITED STATES;

EID: 84922754618     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2725     Document Type: Article

References (31)

1. Alberti KG, Zimmet P, Shaw J. International Diabetes Federation: a consensus on Type 2 diabetes prevention. Diabet Med. 2007; 24:451-463
2. Liu L, Miura K, Fujiyoshi A, Kadota A, Miyagawa N, Nakamura Y, Ohkubo T, Okayama A, Okamura T, Ueshima H. Impact of Metabolic Syndrome on the Risk of Cardiovascular Disease Mortality in the United States and in Japan. Am J Cardiol. 2014; 113:84-81.
3. Edrey YH, Salmon AB. Revisiting an age-old question regarding oxidative stress. Free Radic Biol Med. 2014; 71C:368-378.
4. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panourgia MP, Invidia L, Celani L, Scurti M, Cevenini E, Castellani GC, Salvioli S. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007 Jan; 128:92-105.
5. Agborsangaya CB, Ngwakongnwi E, Lahtinen M, Cooke T, Johnson JA. Multimorbidity prevalence in the general population: the role of obesity in chronic disease clustering. BMC Public Health. 2013 Dec; 1013:1161.
6. Rasmussen F, Hancox RJ. Mechanisms of obesity in asthma. Curr Opin Allergy Clin Immunol. 2014 Feb; 14:35-43.
7. Dehal A, Garrett T, Tedders SH, Arroyo C, Afriyie-Gyawu E, Zhang J. Body mass index and death rate of colorectal cancer among a national cohort of U.S. adults. Nutr Cancer. 2011; 63:1218-1225.
8. Rodríguez-Hernández H, Simental-Mendía LE, Rodríguez-Ramírez G, Reyes-Romero MA. Obesity and inflammation: epidemiology, risk factors, and markers of inflammation. Int J Endocrinol. 2013; 2013:678159.
9. Han JM, Levings MK. Immune regulation in obesity-associated adipose inflammation. J Immunol. 2013; 191:527-532.
10. González F, Nair KS, Daniels JK, Basal E, Schimke JM. Hyperandrogenism sensitizes mononuclear cells to promote glucose-induced inflammation in lean reproductiveage women. Am J Physiol Endocrinol Metab. 2012; 302:E297-306.
11. Dutta A, Ray MR, Banerjee A. Systemic inflammatory changes and increased oxidative stress in rural Indian women cooking with biomass fuels. Toxicol Appl Pharmacol. 2012; 261:255-262.
12. Shah D, Wanchu A, Bhatnagar A. Interaction between oxidative stress and chemokines: possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis. Immunobiology. 2011; 216:1010-1017.
13. Manco M, Putignani L, Bottazzo GF. Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev. 2010; 31:817-844.
14. Piya MK, Harte AL, McTernan PG. Metabolic endotoxaemia: is it more than just a gut feeling? Curr Opin Lipidol. 2013; 24:78-85.
15. Akushevich I, Kravchenko J, Ukraintseva S, Arbeev K, Kulminski A, Yashin AI. Morbidity risks among older adults with pre-existing age-related diseases. Exp Gerontol. 2013; 48:1395-1401.
16. Quiñones AR, Liang J, Bennett JM, Xu X, Ye W. How does the trajectory of multimorbidity vary across Black, White, and Mexican Americans in middle and old age? J Gerontol B Psychol Sci Soc Sci. 2011; 66:739-749.
17. Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer. 2003; 89:1028-1030.
18. van Holten TC, Waanders LF, de Groot PG, Vissers J, Hoefer IE, Pasterkamp G, Prins MW, Roest M. Circulating biomarkers for predicting cardiovascular disease risk; a systematic review and comprehensive overview of metaanalyses. PLoS One. 2013; 8:e62080.
19. Kelly E, Owen CA, Pinto-Plata V, Celli BR. The role of systemic inflammatory biomarkers to predict mortality in chronic obstructive pulmonary disease. Expert Rev Respir Med. 2013; 7:57-64.
20. Deligeoroglou E, Vrachnis N, Athanasopoulos N, Iliodromiti Z, Sifakis S, Iliodromiti S, Siristatidis C, Creatsas G. Mediators of chronic inflammation in polycystic ovarian syndrome. Gynecol Endocrinol. 2012; 28:974-978.
21. Fassett RG, Venuthurupalli SK, Gobe GC, Coombes JS, Cooper MA, Hoy WE. Biomarkers in chronic kidney disease: a review. Kidney Int. 2011; 80:806-821.
22. McMillan DC. An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc. 2008; 67:257-62.
23. Kato A, Tsuji T, Sakao Y, Ohashi N, Yasuda H, Fujimoto T, Takita T, Furuhashi M, Kumagai H. A comparison of systemic inflammation-based prognostic scores in patients on regular hemodialysis. Nephron Extra. 2013 Oct; 113:91-100.
24. McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013 Aug; 39:534-40.
25. Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, Tracy RP. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes. 2001; 50:2384-2389.
26. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes. 2004; 53:693-700.
27. Brunner EJ, Kivimäki M, Witte DR, Lawlor DA, Davey Smith G, Cooper JA, Miller M, Lowe GD, Rumley A, Casas JP, Shah T, Humphries SE, Hingorani AD, Marmot MG, Timpson NJ, Kumari M. Inflammation, insulin resistance, and diabetes-Mendelian randomization using CRP haplotypes points upstream. PLoS Med. 2008; 5:e155.
28. Salvioli S, Monti D, Lanzarini C, Conte M, Pirazzini C, Bacalini MG, Garagnani P, Giuliani C, Fontanesi E, Ostan R, Bucci L, Sevini F, Yani SL, Barbieri A, Lomartire L, Borelli V, Vianello D, Bellavista E, Martucci M, Cevenini E, Pini E, Scurti M, Biondi F, Santoro A, Capri M, Franceschi C. Immune system, cell senescence, aging and longevity-inflamm-aging reappraised. Curr Pharm Des. 2013; 19:1675-9.
29. Stepanova M, Rafiq N, Younossi ZM. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. J Hepatol. 2010; 59:1410-1415.
30. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics. 2005; 115:e500-3.
31. Centers for Disease Control. National Health and Examination Survey: Analytic Guidelines, 2011-2013. http://www.cdc.gov/nchs/data/nhanes/analytic_guidelines_11_12.pdf. Accessed 14 December 2013.